BR9508718A - Estabelecimento e método para segregação de estrógeno tónico de ovário para regimes terapéuticos estendidos - Google Patents

Estabelecimento e método para segregação de estrógeno tónico de ovário para regimes terapéuticos estendidos

Info

Publication number
BR9508718A
BR9508718A BR9508718A BR9508718A BR9508718A BR 9508718 A BR9508718 A BR 9508718A BR 9508718 A BR9508718 A BR 9508718A BR 9508718 A BR9508718 A BR 9508718A BR 9508718 A BR9508718 A BR 9508718A
Authority
BR
Brazil
Prior art keywords
tonic
estrogen
segregation
ovarian
establishment
Prior art date
Application number
BR9508718A
Other languages
English (en)
Inventor
Gary D Hodgen
Audrey Philips
Original Assignee
Hampton Roads Medical College
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26959766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9508718(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/467,860 external-priority patent/US5658884A/en
Application filed by Hampton Roads Medical College, Ortho Pharma Corp filed Critical Hampton Roads Medical College
Publication of BR9508718A publication Critical patent/BR9508718A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9508718A 1994-07-22 1995-07-18 Estabelecimento e método para segregação de estrógeno tónico de ovário para regimes terapéuticos estendidos BR9508718A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27959394A 1994-07-22 1994-07-22
US08/467,860 US5658884A (en) 1994-07-22 1995-06-06 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
PCT/US1995/008996 WO1996003138A1 (en) 1994-07-22 1995-07-18 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens

Publications (1)

Publication Number Publication Date
BR9508718A true BR9508718A (pt) 1997-12-30

Family

ID=26959766

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508718A BR9508718A (pt) 1994-07-22 1995-07-18 Estabelecimento e método para segregação de estrógeno tónico de ovário para regimes terapéuticos estendidos

Country Status (29)

Country Link
EP (1) EP0769956B1 (pt)
JP (1) JP3138477B2 (pt)
CN (1) CN1137722C (pt)
AP (1) AP775A (pt)
AT (1) ATE190494T1 (pt)
AU (1) AU691952B2 (pt)
BG (1) BG63363B1 (pt)
BR (1) BR9508718A (pt)
CA (1) CA2195745C (pt)
CY (1) CY2228B1 (pt)
CZ (1) CZ291803B6 (pt)
DE (1) DE69515666T2 (pt)
DK (1) DK0769956T3 (pt)
EE (1) EE03515B1 (pt)
ES (1) ES2145286T3 (pt)
FI (1) FI970244A (pt)
GR (1) GR3033590T3 (pt)
HU (1) HU218910B (pt)
IL (1) IL114655A (pt)
IS (1) IS4413A (pt)
LV (1) LV11823B (pt)
MX (1) MX9700574A (pt)
NO (1) NO970257L (pt)
NZ (1) NZ290554A (pt)
OA (1) OA10730A (pt)
PT (1) PT769956E (pt)
RU (1) RU2181598C2 (pt)
SK (1) SK282118B6 (pt)
WO (1) WO1996003138A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173592B1 (en) 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
NZ534836A (en) * 1999-09-23 2007-07-27 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferatoin of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
GB0616111D0 (en) * 2006-06-16 2006-09-20 Ardana Bioscience Ltd Agents, methods and uses
EP2095818A1 (en) * 2008-02-29 2009-09-02 AEterna Zentaris GmbH Use of LHRH antagonists at non-castrating doses
US20110129532A1 (en) * 2008-05-29 2011-06-02 Isr Immune System Regulation Ab Method and means for treating viral disease, in particular hiv/aids
WO2016184829A1 (en) * 2015-05-18 2016-11-24 Nerre Therapeutics Limited Dual nk-1/nk-3 receptor antagonists for the treatment of sex-hormone-dependent diseases
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5169932A (en) * 1989-10-30 1992-12-08 The Salk Institute For Biological Studies Gnrh analogs
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
JP3138477B2 (ja) 2001-02-26
AP9700913A0 (en) 1997-01-31
ATE190494T1 (de) 2000-04-15
IL114655A (en) 2005-08-31
DK0769956T3 (da) 2000-06-05
JPH10503203A (ja) 1998-03-24
OA10730A (en) 2001-06-07
AP775A (en) 1999-10-28
EE9700208A (et) 1998-02-16
CY2228B1 (en) 2003-04-18
FI970244A0 (fi) 1997-01-21
ES2145286T3 (es) 2000-07-01
HU218910B (hu) 2000-12-28
EP0769956B1 (en) 2000-03-15
NZ290554A (en) 2000-08-25
RU2181598C2 (ru) 2002-04-27
WO1996003138A1 (en) 1996-02-08
NO970257D0 (no) 1997-01-21
IL114655A0 (en) 1995-11-27
LV11823A (lv) 1997-08-20
EE03515B1 (et) 2001-10-15
PT769956E (pt) 2000-07-31
CN1200674A (zh) 1998-12-02
CZ291803B6 (cs) 2003-06-18
DE69515666T2 (de) 2000-07-06
IS4413A (is) 1997-01-14
HUT77127A (hu) 1998-03-02
CZ15097A3 (en) 1997-11-12
HU9700046D0 (en) 1997-02-28
SK7097A3 (en) 1997-11-05
EP0769956A4 (en) 1999-03-10
GR3033590T3 (en) 2000-09-29
AU3132095A (en) 1996-02-22
BG101158A (en) 1997-09-30
BG63363B1 (bg) 2001-11-30
NO970257L (no) 1997-01-21
EP0769956A1 (en) 1997-05-02
DE69515666D1 (de) 2000-04-20
LV11823B (en) 1998-03-20
MX9700574A (es) 1997-12-31
AU691952B2 (en) 1998-05-28
CN1137722C (zh) 2004-02-11
FI970244A (fi) 1997-01-21
CA2195745A1 (en) 1996-02-08
CA2195745C (en) 2005-03-29
SK282118B6 (sk) 2001-11-06

Similar Documents

Publication Publication Date Title
NO984806D0 (no) Geleringsmiddel for hydrokarbonvµske og anvendelsesmetode
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
NO984545D0 (no) Anordning og fremgangsmÕte for gruspakking
ID27614A (id) Metode dan radas untuk terapi gelombang
NO972982L (no) Anordning og fremgangsmåte ved cellulær kommunikasjon
KR100309483B1 (ko) 기체분석방법및장치
DE69835020D1 (de) Plasmabrenner und verwendungsverfahren dieses plasmabrenners
BR9505870A (pt) Método e aparelho de fundição continua de cilindro duplo
NO20010359L (no) Anordning og fremgangsmÕte for gruspakking av Õpent hull
IL125580A0 (en) Method of and apparatus for producing power
GB9912450D0 (en) Portable apparatus for preventing diffusion and landing of outflow oil
DK0892035T3 (da) Flerfaseemulsion og fremgangsmåde til fremstilling heraf
NO960737L (no) Apparat og fremgangsmåte for polymerisasjon av olefin i gassfase
DE69820278D1 (de) Mischverfahren und mischvorrichtung
NO980257D0 (no) Forankringsinnretning, og fremgangsmåte ved forankring
BR9508718A (pt) Estabelecimento e método para segregação de estrógeno tónico de ovário para regimes terapéuticos estendidos
GB2322592B (en) Method of fixing packing and structure for fixing packing
NO940801L (no) Fremgangsmåte og komponenter for alternativ forskaling
NO964190D0 (no) Terapeutisk smertestillende middel samt fremgangsmåte ved fremstilling derav
NO993963D0 (no) Anordning og fremgangsmÕte til induksjonsforsegling
PL325110A1 (en) Method of treating combustion gas and apparatus therefor
LT97021A (en) Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
PL329666A1 (en) Method of and apparatus for performing continuous gluing operations
PL329118A1 (en) Butadiene derivatives and method of obtaining them
AU1964599A (en) Method for producing variable mixtures of cyclohexylamine and dicyclohexylamine

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B25D Requested change of name of applicant approved
B15G Petition not considered as such [chapter 15.7 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: SURERE-SE O INDEFERIMENTO DO PEDIDO COM BASE NOS ARTS. 10 ( VIII ) E 15 DA LEI 9.279 DE 14/05/96. COMBINADO COM O ART. 37 DA LEI 9.279 DE 14/05/96.

B12B Appeal against refusal [chapter 12.2 patent gazette]